European Commission Approves MSD’s ENFLONSIA™ for Prevention of RSV Lower Respiratory Tract Disease in Infants
MSD has announced European Commission approval for ENFLONSIA™ (clesrovimab) for the prevention of RSV lower respiratory tract disease in newborns and infants during their first RSV season.
Read more